NCT00965991View on ClinicalTrials.gov

Metformin Compared to Glyburide in Gestational Diabetes

NACompletedINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

May 31, 2008

Study Completion Date

August 31, 2023

Conditions
Gestational Diabetes
Interventions
DRUG

metformin

patients received glyburide initial dose of 500 mg PO BID. Increased as necessary to a maximum dose of 2000 mg QD to control blood glucose

DRUG

Glyburide

Initial dose of 2.5mg PO BID increased as necessary to a maximum dose of 20 mg (10mg BID) QD to control blood glucose

Trial Locations (1)

87131

University of New Mexico Diabetes in Pregnancy Clinic, Albuquerque

All Listed Sponsors
lead

University of New Mexico

OTHER

NCT00965991 - Metformin Compared to Glyburide in Gestational Diabetes | Biotech Hunter | Biotech Hunter